Advertisement OctoPlus in manufacturing pact with French biotechnology firm - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

OctoPlus in manufacturing pact with French biotechnology firm

OctoPlus has entered into a pharmaceutical manufacturing contract with a French biotechnology company.

OctoPlus said that the undisclosed contract value will make a material contribution to its’ annual revenues.

As per the contract terms, OctoPlus is expected to perform clinical manufacturing for the client’s product candidate.

OctoPlus provides formulation development and clinical material manufacturing services to biotech and pharmaceutical companies worldwide.

In addition OctoPlus offers its clients drug delivery technologies for the development of controlled release versions of existing or new drugs.